Magnetic resonance imaging features of focal liver lesions after intervention

Topics in Magnetic Resonance Imaging

Volumn 16, Issue 1, 2005, Pages 99-106

  Braga, Larissa ^a,b   Semelka, Richard C ^b  

^a University of North Carolina at Chapel Hill   (United States)

^b UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

Author keywords

Interventional procedures; Liver neoplasms; Magnetic resonance

Indexed keywords

ANTINEOPLASTIC AGENT; GADOLINIUM;

CHEMOEMBOLIZATION; CHEMOTHERAPY; CLINICAL FEATURE; HUMAN; LIVER CANCER; LIVER INJURY; LIVER RESECTION; LIVER TRANSPLANTATION; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; RADIATION; RADIATION INJURY; RADIOFREQUENCY ABLATION; REVIEW; TUMOR RECURRENCE;

HUMANS; IMAGE ENHANCEMENT; IMAGE INTERPRETATION, COMPUTER-ASSISTED; LIVER NEOPLASMS; MAGNETIC RESONANCE IMAGING; NEOPLASM RECURRENCE, LOCAL; PHYSICIAN'S PRACTICE PATTERNS; PRACTICE GUIDELINES; PROGNOSIS; WHOLE BODY IMAGING;

EID: 31944437027     PISSN: 08993459     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.rmr.0000189026.57872.8c     Document Type: Review

References (47)

1. Bilimoria MM, Lauwers GY, Doherty DA, et al. Underlying liver disease, not tumor factors, predicts long-term survival after resection of hepatocellular carcinoma. Arch Surg. 2001;136:528-535.
2. Harmon KE, Ryan JA Jr, Biehl TR, et al. Benefits and safety of hepatic resection for colorectal metastases. Am J Surg. 1999;177:402-404.
3. Holbrook RF, Koo K, Ryan JA. Resection of malignant primary liver tumors. Am J Surg. 1996;171:453-455.
4. Goshima S, Kanematsu M, Matsuo M, et al. Malignant hepatic tumor detection with ferumoxide-enhanced magnetic resonance imaging: Is chemical-shift-selective fat suppression necessary for fast spin-echo sequence? J Magn Reson Imaging. 2004;20:75-82.
5. Arrive L, Hricak H, Goldberg HI, et al. MR appearance of the liver after partial hepatectomy. AJR Am J Roentgenol. 1989;152:1215-1220.
6. Soyer P, Bluemke DA, Zeitoun G, et al. Detection of recurrent hepatic metastases after partial hepatectomy: value of CT combined with arterial portography. AJR Am J Roentgenol. 1994;162:1327-1330.
7. Haran EF, Maretzek AF, Goldberg I, et al. Tamoxifen enhances cell death in implanted MCF7 breast cancer by inhibiting endothelium growth. Cancer Res. 1994;54:5511-5514.
8. Braga L, Semelka RC, Pietrobon R, et al. Does hypervascularity of liver metastases as detected on MRI predict disease progression in breast cancer patients? AJR Am J Roentgenol. 2004;182:1207-1213.
9. Semelka RC, Braga L, Armao D, et al. Liver. In: Semelka RC, ed. Abdominal-Pelvic MRI. New York: Wiley-Liss; 2002.
10. Semelka RC, Worawattanakul S, Noone TC, et al. Chemotherapy-treated liver metastases mimicking hemangiomas on MR images. Abdom Imaging. 1999;24:378-382.
11. Ohtomo K, Itai Y, Yoshikawa K, et al. MR imaging of hepatoma treated by embolization. J Comput Assist Tomogr. 1986;10:973-975.
12. De Santis M, Torricelli P, Christani A, et al. MRI of hepatocellular carcinoma before and after transcatheter chemoembolization. J Comput Assist Tomogr. 1993;17:901-908.
13. Semelka RC, Shoenut JP, Krosker RM. T2-weighted MR imaging of focal hepatic lesions: comparison of various RARE and fat-suppressed spin-echo sequences. J Magn Reson Imaging. 1993;3:323-327.
14. Burdeny DA, Semelka RC, Kelekis NL, et al. Chemotherapy treated liver metastases mimicking hemangiomas on MR images. Abdom Imaging. 1999;24:378-382.
15. Noone TC, Semelka RC, Balci NC, et al. Common occurrence of benign liver lesions in patients with newly diagnosed breast cancer investigated by MRI for suspected liver metastases. J Magn Reson Imaging. 1999;10:165-169.
16. Semelka RC, Worawattanakul S, Mauro M, et al. Malignant hepatic tumors: changes on MRI after hepatic arterial chemoembolization - preliminary findings. J Magn Reson Imaging. 1998;8:48-56.
17. Bartolozzi C, Lencioni R, Caramella D, et al. Hepatocellular carcinoma: CT and MR features after transcatheter arterial embolization and percutaneous ethanol injection. Radiology. 1994;191:123-128.
18. Lee MJ, Mueller PR, Dawson SL, et al. Percutaneous ethanol injection for the treatment of hepatic tumors: indications, mechanism of action, technique, and efficacy. AJR Am J Roentgenol. 1995;164:215-220.
19. Lang EK, Brown CL Jr. Colorectal metastases to the liver: selective chemoembolization. Radiology. 1993;189:417-422.
20. Martin DR, Semelka RC, Chung JJ, et al. Sequential use of gadolinium chelate and mangafodipir trisodium for the assessment of focal liver lesions: initial observations. Magn Reson Imaging. 2000;18:955-963.
21. Ros PR, Freeny PC, Marms SE, et al. Hepatic MR imaging with ferumoxides: a multicenter clinical trial of the safety and efficacy in the detection of focal hepatic lesions. Radiology. 1995;196:481-488.
22. Montet X, Lazeyras F, Howarth N, et al. Specificity of SPIO particles for characterization of liver hemangiomas using MRI. Abdom Imaging. 2004;29:60-70.
23. Goldberg SN, Gazelle GS, Mueller PR. Thermal ablation therapy for focal malignancy: a unified approach to underlying principles, techniques, and diagnostic imaging guidance. AJR Am J Roentgenol. 2000;174:323-331.
24. Kuszyk BS, Boitnott JK, Choti MA, et al. Local tumor recurrence following hepatic cryoablation: radiologic-histopathologic correlation in a rabbit model. Radiology. 2000;217:477-486.
25. Goldberg SN, Gazelle GS, Compton CC, et al. Treatment of intrahepatic malignancy with radiofrequency ablation: radiologic-pathologic correlation. Cancer. 2000;88:2452-2463.
26. Dromain C, de Baere T, Elias D, et al. Hepatic tumors treated with percutaneous radio-frequency ablation: CT and MR imaging follow-up. Radiology. 2002;223:255-262.
27. Limanond P, Zimmerman P, Raman SS, et al. Interpretation of CT and MRI after radiofrequency ablation of hepatic malignancies. AJR Am J Roentgenol. 2003;181:1635-1640.
28. Goldberg SN, Charboneau JW, Dodd GD 3rd, et al. International Working Group on Image-Guided Tumor Ablation. Image-guided tumor ablation: proposal for standardization of terms and reporting criteria. Radiology. 2003;228:335-345.
29. Lim HK, Choi D, Lee WJ, et al. Hepatocellular carcinoma treated with percutaneous radio-frequency ablation: evaluation with follow-up multi-phase helical CT. Radiology. 2001;221:447-454.
30. Choi D, Lim HK, Kim MJ, et al. Recurrent hepatocellular carcinoma: percutaneous radiofrequency ablation after hepatectomy. Radiology. 2004;230:135-141.
31. Semelka RC. Metastatic liver tumor: circumferential versus wedge-shaped perilesional enhancement and quantitative image and pathologic correlation. Radiology. 2001;219:298-300.
32. Semelka RC, Hussain SM, Marcos HB, et al. Perilesional enhancement of hepatic metastases: correlation between MR imaging and histopathologic findings - initial observations. Radiology. 2000;215:89-94.
33. Kuszyk BS, Boitnott JK, Choti MA, et al. Local tumor recurrence following hepatic cryoablation: radiologic-histopathologic correlation in a rabbit model. Radiology. 2000;217:477-486.
34. Chopra S, Dodd GD 3rd, Chanin MP, et al. Radiofrequency ablation of hepatic tumors adjacent to the gallbladder: feasibility and safety. AJR Am J Roentgenol. 2003;180:697-701.
35. Joseph FB, Baumgarten DA, Bernardino ME. Hepatocellular carcinoma: CT appearance after percutaneous ethanol ablation therapy. Work in progress. Radiology. 1993;186:553-556.
36. Mitsuzaki K, Yamashita Y, Nishiharu T, et al. CT appearance of hepatic tumors after microwave coagulation therapy. AJR Am J Roentgenol. 1998;171:1397-1403.
37. Schlund JF, Semelka RC, Kettritz U, et al. Correlation of perfusion abnormalities on CTAP and immediate postintravenous gadolinium-enhanced gradient echo MRI. Abdom Imaging. 1996;21:49-52.
38. Sahara D, D'souza R, Kadavigere R, et al. Evaluation of living liver transplant donors: method for precise anatomic definition by using a dedicated contrast-enhanced MR imaging protocol. Radiographics. 2004;24:957-967.
39. Wozney P, Zajko AB, Bron KM, et al. Vascular complications after liver transplantation: a 5-year experience. AJR Am J Roentgenol. 1986;147:657-663.
40. Glockner JF, Forauer AR, Solomon H, et al. Three-dimensional gadolinium-enhanced MR angiography of vascular complications after liver transplantation. AJR Am J Roentgenol. 2000;174:1447-1452.
41. Stafford-Johnson DB, Hamilton BH, Dong Q, et al. Vascular complications of liver transplantation: evaluation with gadolinium-enhanced MR angiography. Radiology. 1998;207:153-160.
42. Kim BS, Kim TK, Jung DJ, et al. Vascular complications after living related liver transplantation: evaluation with gadolinium-enhanced three-dimensional MR angiography. AJR Am J Roentgenol. 2003;181:467-474.
43. Marincek B, Barbier PA, Becker CD, et al. CT appearance of impaired lymphatic drainage in liver transplants. AJR Am J Roentgenol. 1986;147:519-523.
44. Pickhardt PJ, Siegel MJ. Posttransplantation lymphoproliferative disorders of the abdomen: CT evaluation in 51 patients. Radiology. 1999;213:73-78.
45. Strouse PJ, Platt JF, Francis IR, et al. Tumorous intrahepatic lymphoproliferative disorder in transplanted livers. AJR Am J Roentgenol. 1996;167:1159-1162.
46. Ito K, Siegelman ES, Stolpen AH, et al. MR imaging of complications after liver transplantation. AJR Am J Roentgenol. 2000;175:1145-1149.
47. Zajko AB, Bennett MJ, Campbell WL, et al. Mucocele of the cystic duct remnant in eight liver transplant recipients: findings at cholangiography, CT, and US. Radiology. 1990;177:691-693.